-
Mashup Score: 3Efstathiou on the Status of Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer - 1 month(s) ago
Jason Efstathiou, MD, discusses the status of bladder preservation therapy for muscle-invasive bladder cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Efstathiou on the Status of Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer - 1 month(s) ago
Jason Efstathiou, MD, discusses the status of bladder preservation therapy for muscle-invasive bladder cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Efstathiou on the Status of Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer @MGHCancerCenter @harvardmed @acroradonc #ACRO2024 https://t.co/OjzPk3ZOdA
-
-
Mashup Score: 4
Steven E. Finkelstein, MD, DABR, FACRO, discusses the importance of disseminating treatment advancements and ongoing research in radiation oncology.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
2024 ACRO Summit Underscores the Importance of Continued Education in Radiation @ACRORadOnc #ACRO2024 https://t.co/OztW21AONq
-
-
Mashup Score: 3Efstathiou on the Status of Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer - 1 month(s) ago
Jason Efstathiou, MD, discusses the status of bladder preservation therapy for muscle-invasive bladder cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Efstathiou on the Status of Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer @MGHCancerCenter @harvardmed @acroradonc #ACRO2024 https://t.co/OjzPk3ZOdA
-
-
Mashup Score: 4
Steven E. Finkelstein, MD, DABR, FACRO, discusses the importance of disseminating treatment advancements and ongoing research in radiation oncology.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
2024 ACRO Summit Underscores the Importance of Continued Education in Radiation @ACRORadOnc #ACRO2024 https://t.co/OztW21AONq
-
-
Mashup Score: 2
Robert W. Mutter, MD, discusses the nuances of partial breast irradiation in early-stage breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Mutter Discusses Partial Breast Irradiation in Low-Risk Breast Cancer. @ACRORadOnc #ACRO2024 https://t.co/rc9Wtj4TrM
-
-
Mashup Score: 3
Steven E. Finkelstein, MD, DABR, FACRO, discusses the importance of disseminating treatment advancements and ongoing research in radiation oncology.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
2024 ACRO Summit Underscores the Importance of Continued Education in Radiation @ACRORadOnc #ACRO2024 https://t.co/OztW21AONq
-
-
Mashup Score: 1
Robert W. Mutter, MD, discusses the nuances of partial breast irradiation in early-stage breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Mutter Discusses Partial Breast Irradiation in Low-Risk Breast Cancer. @ACRORadOnc #ACRO2024 https://t.co/rc9Wtj4TrM
-
-
Mashup Score: 1
Vlad Gabriel Zaha, MD, PhD, discusses the risk of cardiovascular toxicity in patients with lung cancer undergoing treatment with radiation.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
WATCH: Vlad Gabriel Zaha, MD, PhD, discusses the risk of cardiovascular toxicity in patients with lung cancer undergoing treatment with radiation. #ACRO2024 https://t.co/Fw45QzHiAW
-
-
Mashup Score: 2
Learn the latest research in radiation oncology while networking with its brightest minds. Click here for the 2023 agenda & here for the resident/med student agenda. Continuing Education Credits are available for this program. Details are on the agenda. Check out the agenda for our ACRO SEALS (Rad Onc Leaders) in 2023. Click here to learn how to get involved as a
Source: acro.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @ACRORadOnc: The word is out! Early bird registration is now open for #ACRO2024! Register at: https://t.co/OBoQ13xPcn https://t.co/vox2o…
-
Efstathiou on the Status of Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer @MGHCancerCenter @harvardmed @acroradonc #ACRO2024 https://t.co/OjzPk3ZOdA